![Johan Rutger Christenson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Johan Rutger Christenson
Vorsitzender bei
Aprea Personal AB
Profil
Johan Rutger Christenson is currently the Chairman of Aprea Personal AB and a Director of BeneChill, Inc., Cerenis Therapeutics, Inc., Healthcap 1999 GP AB, InCarda Therapeutics, Inc., Ancilla AB, Glionova AB, Healthcap Aero Holdings Gp, Healthcap Orx Holdings Gp AB, Trimb Holding AB, and a Partner at HealthCap AB. He previously held positions as Vice Chairman at Nexstim Oyj, Director at Medtronic CoreValve LLC, Director-Global Product at AstraZeneca AB, Director at Neuro3D SA, Director at Orexo AB, Director at Resistentia Pharmaceuticals AB, Director at Newron Sweden AB, Director at Oncopeptides AB, Director at TopoTarget UK Ltd., Non-Executive Director at ABIONYX Pharma SA, Director at Aprea Therapeutics AB, Director at Targovax Oy, Director at Algeta US LLC, Project Director at Astra Pain Control AB, and Principal at Odlander, Fredrikson & Co. AB. He also served as the Assistant Dean-Graduate School at Karolinska Institutet and Principal at SEB Venture Capital.
He holds a doctorate degree from Karolinska Institutet.
Aktive Positionen von Johan Rutger Christenson
| Unternehmen | Position | Beginn |
|---|---|---|
Ancilla AB
 Ancilla AB Real Estate DevelopmentFinance Manages real estate properties | Direktor/Vorstandsmitglied | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Private Equity Investor | 01.01.2001 |
BeneChill, Inc.
 BeneChill, Inc. Medical SpecialtiesHealth Technology Develops non-invasive cooling technology for cerebral ischemia treatment | Direktor/Vorstandsmitglied | 21.07.2009 |
Trimb Holding AB
 Trimb Holding AB Financial ConglomeratesFinance Operates as a holding company with interest in pharmaceuticals | Direktor/Vorstandsmitglied | - |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Direktor/Vorstandsmitglied | - |
Glionova AB
 Glionova AB BiotechnologyHealth Technology Develops cancer treatment drugs | Direktor/Vorstandsmitglied | - |
Aprea Personal AB | Vorsitzender | - |
Healthcap Aero Holdings Gp | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Johan Rutger Christenson
| Unternehmen | Position | Ende |
|---|---|---|
| FUSN PHAR | Direktor/Vorstandsmitglied | 16.10.2023 |
| ░░░░░░░░░ ░░░░ ░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Johan Rutger Christenson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
35
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 35 |
|---|---|
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
BeneChill, Inc.
BeneChill, Inc. Medical SpecialtiesHealth Technology Develops non-invasive cooling technology for cerebral ischemia treatment | Health Technology |
Medtronic CoreValve LLC
 Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Develops products that provide alternetive to heart valve replacement surgery | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Odlander, Fredrikson & Co. AB
 Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Provides financial services | Finance |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuro3D SA
 Neuro3D SA Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products to treat the central nervous system | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
SEB Venture Capital
 SEB Venture Capital Investment ManagersFinance SEB Venture Capital invests in emerging companies located in Sweden. The firm targets companies operating in the fields technology sector, FinTech. It provides financing for early stage capital requirements with an investment size of SEK 10 - 100 million. | Finance |
Resistentia Pharmaceuticals AB
 Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops immunotherapy products | Health Technology |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Health Technology |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Nexstim Oyj
 Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Retail Trade |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Healthcap 1999 GP AB
 Healthcap 1999 GP AB Investment Banks/BrokersFinance Manages and trading securities | Finance |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Focuses on the development and commercialization of targeted cancer immunotherapy | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Health Technology |
Aprea Personal AB | |
Algeta US LLC
 Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Trimb Healthcare AB
 Trimb Healthcare AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and consumer healthcare products | Health Technology |
Ancilla AB
Ancilla AB Real Estate DevelopmentFinance Manages real estate properties | Finance |
Glionova AB
Glionova AB BiotechnologyHealth Technology Develops cancer treatment drugs | Health Technology |
Astra Pain Control AB | |
Healthcap Aero Holdings Gp | |
HealthCap Holdings GP AB
 HealthCap Holdings GP AB Investment ManagersFinance Provides investment advisory services | Finance |
Healthcap Orx Holdings Gp AB
 Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Engages in managing of securities | Finance |
Trimb Holding AB
Trimb Holding AB Financial ConglomeratesFinance Operates as a holding company with interest in pharmaceuticals | Finance |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
